Clinical Trial Update: e-PAT Neuromod Evaluation of Personalized rTMS for Resistant Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating personalized e-PAT neuromodulation with repetitive transcranial magnetic stimulation for treatment-resistant depression was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Depressive Disorder, Treatment-Resistant | Phase 2 | Status: WITHDRAWN